If takeover offer fails, Exiqon risks short-term

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
If takeover offer fails, Exiqon risks short-term profitability and plans for a capital increase to accelerate life sciences strategy

Copenhagen, 2016-05-24 08:51 CEST (GLOBE NEWSWIRE) -- Announcement No. 13/2016

To Nasdaq Copenhagen   

Exiqon A/S (Nasdaq Copenhagen: “EXQ”) today reiterated the Board of Directors’ support to the takeover offer submitted by QIAGEN N.V to buy the share capital of Exiqon A/S . I f the takeover offer is not completed on or before 6 June 2016 in accordance with the recently announced extension of the offer period, Exiqon plans to focus future activities .

In a comment, Erik Walldén, Chairman of the Board of Directors of Exiqon A/S, said: 

“If QIAGEN cannot complete their offer after the extended offer period, despite a recommendation by a unanimous Board of Directors to accept the offer, we need a new plan for the future stand-alone scenario that has the potential of generating longer term shareholder value above the current offer. Our industry is highly consolidated and size is increasingly becoming a competitive parameter. To more rapidly achieve size, we must accelerate revenue growth. We therefore plan to focus our resources on life sciences at the expense of our publically funded activities within diagnostics. Through a new financing round, we expect to invest more aggressively on two fronts; the development of new proprietary products, and the commercialization of our recently launched XploreRNA™ platform. In the short term, we may risk compromising our recently gained bottom line profitability, however, increased investment is necessary to achieve higher growth, which is critically important for Exiqon to develop a business that is sustainable in the long term.“

Exiqon plans to accelerate the company’s current Life Sciences strategy on two fronts (i) increased investment in to the company’s research and development of proprietary products including new products for RNA sequencing, (ii) increased investment in to the commercialization of XploreRNA™, a new proprietary sales channel developed by Exiqon that holds promise of transforming industry work-flows by integrating RNAseq data analysis with custom assay design capabilities.

Additional capital will be required to finance the planned investments designed to accelerate the company’s growth and achieve long-term sustainable profitability. 

In consequence of the increased strategic focus, Exiqon plans to discontinue its current Diagnostic segment and write down all associated goodwill of DKK 49.4 million. The company’s current diagnostic activities are financed by grant income that will expire shortly and new public funding is becoming less available. The company will only continue the development of the most promising program(s) and seek to commercialize any successfully developed products for diagnostic applications in line with the company’s strategy that relies on partners to obtain regulatory approvals, market, and sell its diagnostic tests. Exiqon is not a diagnostic company. When the offer period is concluded, the company’s full year financial guidance will be revised to reflect the write down of goodwill and total costs associated with the takeover offer by QIAGEN N.V. 

Exiqon plans to call for an extraordinary general meeting after 6 June 2016 to seek approval from the company’s shareholders to increase the current share capital when the company’s share price has stabilized.

Additional information

Erik Walldén, Chairman of the Board of Directors, Mobile: +46 70 225 2270

About Exiqon

At Exiqon, we advance the research of when and where genes are expressed. We empower scientists across the world with best-in-class products and user-friendly business solutions designed to transform workflows in our industry. Exiqon operates in two business areas: Exiqon Life Sciences is a leading provider of flexible solutions for gene expression analysis. Academia, biotech and pharmaceutical companies around the world use Exiqon’s research products to make ground-breaking discoveries. Exiqon Diagnostics collaborates with diagnostic and pharmaceutical companies to develop novel molecular diagnostic tests for early detection of diseases, which can help physicians make better treatment decisions. Exiqon is listed on Nasdaq Copenhagen. For more information about us, please visit www.exiqon.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Voltage Energy's Microgrid Launches at RE+ 2026

Updated Category News Views 192

Voltage Energy Unveils New Power Systems In the swirling chaos of energy innovation, Voltage Energy is trying to carve its path at the heart of RE+ 2026. Out in Las Vegas, amidst the buzz of renewable energy tech, they introduced their Microgrid System (MGS) along with two new electrical balance of system (EBOS) products—the Load Break Disconnect Box (LBD) and Combiner...

Continue Reading
ETCO Targets the Unflashy Weak Link in Battery Storage

Updated Category News Views 0

A battery cabinet can look impressive right up until one lousy connection becomes the problem nobody budgeted for. ETCO Incorporated’s new lineup of standard and custom connectors and terminals goes after that unglamorous part of battery energy storage systems: the physical handoff points carrying power, grounding equipment, and tying auxiliary components together. It...

Continue Reading
Holiday Grease Advice Shows Utility Work Up Close Today

Updated Category News Views 117

Butter and pan drippings are mundane right until they become a backed-up kitchen line on a crowded holiday afternoon. New Jersey American Water's Nov. 17, 2026 reminder is not glamorous utility news, and frankly it is not trying to be. It is a practical warning: fats, oils and grease can cool, harden and accumulate in household pipes and farther along the wastewater...

Continue Reading
Insider Risk Makes Human Judgment a Security Priority

Updated Category News Views 87

A badge, a password, and a locked gate can all look reassuring right up until the person holding them starts to crack. Signpost Six's new report, The Psychology of Insider Risk, lands on an uncomfortable truth: the most consequential security weakness may not be a system at all. It may be an employee under strain, in conflict, in debt, making a mistake, or being quietly...

Continue Reading
COPD Support Program Targets a Costly Care Gap Today

Updated Category News Views 16

Breathing trouble gets shrugged off far too easily, and that casual mistake has consequences. World COPD Day puts chronic obstructive pulmonary disease back in view, with the American Lung Association emphasizing a free Lung Health Navigator program for people living with COPD, their caregivers and families. This is not flashy medicine or a miracle-cure pitch. It is...

Continue Reading
Sola's 11-Step Push Makes Salon Ownership Less Blind

Updated Category News Views 253

A pristine studio does not pay rent by itself. That is the uncomfortable little truth sitting underneath Sola Salons’ new 11-step roadmap for beauty professionals considering salon-suite ownership. The company is telling stylists, estheticians, nail technicians, massage therapists, and other independent operators to treat the move from commission work to ownership like...

Continue Reading
MobileX's $10 Plan Puts Holiday Pressure on Wireless

Updated Category News Views 157

A sixty-dollar commitment is a small bet, but in wireless it can become a loud little nuisance for every carrier charging far more. MobileX has rolled out a Black Friday offer giving new customers 10GB of high-speed data, unlimited talk and text, and six months of service for $60 upfront. That pencils out to $10 a month, before taxes and government surcharges, and it runs...

Continue Reading
Bona's 2027 Floorcast Finds Wood and Trust Still Win

Updated Category News Views 264

Floors are turning into a long-game purchase again Gray flooring may be limping toward the exit, but the more important signal in Bona's 2027 Floorcast is that homeowners are thinking less like bargain hunters and more like custodians of an expensive asset. That is a useful read for anybody watching the home-improvement and maintenance landscape. People do not replace a...

Continue Reading
Toledo Crosswalk Death Lawsuit Raises Hard Questions

Updated Category News Views 249

A painted crosswalk is supposed to mean something, and that is the grim center of the lawsuit filed over Judy Tanner’s death in Toledo. Tanner, 20, was walking home from work on September 10, 2026, when she was struck and killed while crossing the street. Her estate is now suing, alleging that the 31-year-old driver failed to yield as Tanner legally used the crosswalk....

Continue Reading
Modexus Opens a $500 Million Buyback With Real Caveats

Updated Category News Views 0

A half-billion-dollar buyback authorization can make a stock crowd sit up fast, and Modexus Solutions has plainly chosen that moment. On November 18, 2026, the Racine, Wisconsin-based thermal-management company said its board authorized repurchases of up to $500 million of common stock. For holders of NYSE:MOD, that is a meaningful declaration of intent. It says...

Continue Reading

Top 5 Most Recently Viewed Articles

IASO Bio Achieves Major Milestone with Orphan Drug Status

Updated Category News Views 270

IASO Bio Earns Orphan Drug Designation for Breakthrough Therapy IASO Biotherapeutics, a key player in the biopharmaceutical sector, announced an exciting achievement as its groundbreaking treatment, Equecabtagene Autoleucel (Fucaso), received Orphan Drug Designation from the Ministry of Food and Drug Safety. This recognition is particularly significant for adults fighting...

Continue Reading
Transforming Experience: Honda Center's $1 Billion Revamp

Updated Category News Views 387

Transforming Experience: Honda Center's $1 Billion Revamp Honda Center Encore Is A Multi-Year Investment Led by the Samueli Family That Will Redefine the Arena Experience OC Sports & Entertainment (OCSE), connected with the operator of Honda Center, has announced a groundbreaking project known as Honda Center Encore. This ambitious venture involves a significant...

Continue Reading
PIMCO Municipal Income Fund Faces Market Pressures at New Lows

Updated Category News Views 192

PIMCO Municipal Income Fund's Recent Market Performance PIMCO Municipal Income Fund (PMF) has recently faced significant market challenges, as evidenced by its stock hitting a notable 52-week low at a price of $8.82. This decline isn't merely an isolated incident; it reflects ongoing pressures impacting the broader fixed-income sector. Investors are currently navigating...

Continue Reading
Exploring Non-Surgical Solutions for Prostate Health Issues

Updated Category News Views 174

Prostate health became a hot topic for many men over 50, especially with the rise of benign prostatic hyperplasia (BPH)—that uncomfortable enlargement that turns bathroom trips into sprints. Back then, treatment options were shaking up, and PAE was coming onto the scene like it owned the place. PAE vs. Traditional Surgery: The Fight for Relief In an era where...

Continue Reading
Applied Digital Appoints Laura Laltrello as COO for AI Growth

Updated Category News Views 245

Applied Digital Names Laura Laltrello as New COO Applied Digital Corporation (NASDAQ: APLD) is excited to announce the appointment of Laura Laltrello as its new Chief Operating Officer (COO). With an aim to strengthen the Company’s leadership in next-generation data centers and digital cloud solutions, Ms. Laltrello's role signifies a pivotal moment in the Company’s...

Continue Reading